| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.12▲ | 1.13▼ | 1.13▼ | 1.22▼ | 1.34▼ |
| MA10 | 1.12▲ | 1.14▼ | 1.14▼ | 1.37▼ | 1.23▼ |
| MA20 | 1.13▼ | 1.14▼ | 1.20▼ | 1.41▼ | 1.23▼ |
| MA50 | 1.14▼ | 1.23▼ | 1.30▼ | 1.26▼ | 1.12▲ |
| MA100 | 1.14▼ | 1.31▼ | 1.43▼ | 1.25▼ | 1.84▼ |
| MA200 | 1.20▼ | 1.43▼ | 1.30▼ | 1.07▲ | 3.06▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.004▲ | -0.001▼ | -0.052▼ | 0.006▲ |
| RSI | 45.992▼ | 40.165▼ | 36.387▼ | 38.107▼ | 47.264▼ |
| STOCH | 49.444 | 36.536 | 30.088 | 7.297▼ | 50.896 |
| WILL %R | -33.333 | -76.471▼ | -89.231▼ | -93.382▼ | -77.072▼ |
| CCI | 29.613 | -87.252 | -71.776 | -144.680▼ | -36.449 |
|
Tuesday, November 10, 2026 03:42 AM
MaxCyte reports Q3 2026 revenue growth of 49% to $10.2 million and raises full-year revenue guidance to at least $34.5 million.
|
|
Tuesday, November 10, 2026 03:02 AM
On a pro forma basis, excluding the impact of the Akron acquisition and deal-related expenses and other costs related to the Akron acquisition, MaxCyte now expects to end 2026 with approximately $133 ...
|
|
Saturday, September 05, 2026 02:47 AM
MXCT stock reflects MaxCyte's role in cell-therapy technology, with recent market data and the latest reported figures giving investors a clearer picture of the company’s current position in the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 1.13 | 1.19 | 1.105 | 1.125 | 1,932,552 |
| 10/11/26 | 1.40 | 1.42 | 1.08 | 1.13 | 4,481,527 |
| 09/11/26 | 1.25 | 1.35 | 1.25 | 1.30 | 1,599,618 |
| 06/11/26 | 1.31 | 1.36 | 1.24 | 1.26 | 876,060 |
| 05/11/26 | 1.39 | 1.421 | 1.29 | 1.31 | 873,628 |
| 04/11/26 | 1.47 | 1.48 | 1.36 | 1.39 | 856,000 |
| 03/11/26 | 1.51 | 1.51 | 1.365 | 1.46 | 1,030,157 |
| 02/11/26 | 1.59 | 1.705 | 1.43 | 1.45 | 1,283,634 |
| 30/10/26 | 1.71 | 1.72 | 1.505 | 1.59 | 962,127 |
| 29/10/26 | 1.73 | 1.76 | 1.6229 | 1.73 | 1,142,242 |
|
|
||||
|
|
||||
|
|